Cargando…
小分子抗血管生成药物在非小细胞肺癌中的研究进展
Lung cancer is one of the cancers with the highest incidence in the world, and there is no standard treatment plan after second-line progression. Tumor angiogenesis has now been identified as an important therapeutic target for malignant tumors. Small molecule multi-target vascular kinase inhibitors...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849040/ https://www.ncbi.nlm.nih.gov/pubmed/33478192 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.02 |